Centre Hospitalier Universitaire De Nantes
- Address
- lock Available on a paid plan
Dermatology Clinical Research at Centre Hospitalier Universitaire De Nantes
The trial portfolio focuses on Skin and Connective Tissue Diseases, with research centered on atopic dermatitis and eczema. This work is aimed at improving care for people living with chronic inflammatory skin conditions.
- Studies are evaluating new treatment approaches for moderate-to-severe atopic dermatitis.
- Research is assessing whether adding a targeted therapy can improve symptom control compared with standard care.
- The site contributes to pediatric and adolescent dermatology research, including studies in younger patients with eczema.
With 6 clinical trials and a large investigator base, the Nantes site supports active clinical testing in inflammatory skin disease, combining treatment evaluation with efforts to improve outcomes for patients and families.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 38 therapeutic areas and 15 of 1 115 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 1 025 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 209 by active trials.
lock +208 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Assistance Publique Hopitaux De Paris100trials
lock +125 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospitalier Universitaire De Nantes
lock Showing 1 of 1 093 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| (20289) A Phase 2 Basket Study of the Oral TRK Inhibitor larotrectinib in Subjects with NTRK Fusion-Positive Tumors | Bayer AG, Bayer Consumer Care AG | Phase II | Not Recruiting | Jun 2016 | Sep 2025 |
IMP list
lock Showing 1 of 1 115 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dexamethasone | 59 | Unknown | 2016-02-19 | 2026-07-28 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.